Late last year, the American College of Cardiology and the American Heart Association (ACC/AHA) published joint guidance, which recommended lowering the risk threshold at which statins are offered for primary […]
The BMJ today
The BMJ Today: Essential medicines, evidence, and influence
Today an Analysis article questions the quality of applications to the World Health Organization’s essential medicines list. The WHO essential medicines list is a skeletal formulary of medicines that all […]
The BMJ Today: Dabigatran and other new oral anticoagulants—demand the data
Last week, The BMJ published a series of articles that investigated how the safety and effectiveness of the new oral anticoagulant, dabigatran, had been studied, licensed, and subsequently marketed. An […]
The BMJ Today: Improving vaccination rates
In the United States, the Centers for Disease Control and Prevention (CDC) held a press conference to discuss a recent survey, which found that rates of HPV vaccine coverage did […]
The BMJ Today: Bleeding anticoagulants and guerrilla warfare
Can we better quantify the risk of upper gastrointestinal and intracranial bleeding among patients who are taking long term oral anticoagulants for venous thromboembolism, systemic embolism, or stroke prevention? This […]
The BMJ Today: Dabigatran—the impact of The BMJ’s investigation
“The results of this investigation are somewhat shocking to me, but, reviewing the information, not entirely surprising.” That was the verdict of David Haines, section head of the Heart Rhythm […]
The BMJ Today: Feet and fudge
A calcaneal fracture can mean a two year recovery, with a stiff, painful, deformed foot that will not fit into a normal shoe. How does operative and non-operative treatment for […]
The BMJ Today: More on transparency
In recent years, The BMJ has campaigned on transparency—the focus of our Open Data campaign, and an issue of vital importance if modern medicine is to retain the trust of doctors […]
The BMJ Today: Time to rethink your assumptions about sepsis, Minerva
When I first arrived at the University of Bath, to study history and philosophy of science, our first lecture was about Sulis-Minerva: the combination of Minerva, Roman goddess of wisdom, and […]
The BMJ Today: A good idea gone wrong?
At the 2008 World Economic Forum in Davos, Bill Gates highlighted a new US Food and Drug Administration (FDA) law that rewarded sponsors of drugs for tropical diseases with a […]